Chinese Journal of Dermatology ›› 2019, Vol. 52 ›› Issue (12): 934-936.doi: 10.35541/cjd.20180712

• Reviews • Previous Articles     Next Articles

Role of the insulin-like growth factor 1 receptor signaling pathway in the pathogenesis of related skin diseases

Tang Hongyan1, Xiao Bin2, Yang Guilan3   

  1. 1Department of Dermatology, Lanzhou University Second Hospital, Lanzhou 730000, China; 2Department of Dermatology, Changshu No.5 People′s Hospital, Changshu 215500, Jiangsu, China; 3Department of Cosmetic Dermatology and Venereology, Shenzhen Hospital of Southern Medical University, Shenzhen 518000, China
  • Received:2018-08-23 Revised:2019-08-09 Online:2019-12-15 Published:2019-12-02
  • Contact: Yang Guilan E-mail:drgly2006@126.com
  • Supported by:
    Open Research Fund of Ministry of Education Key Laboratory of Dermatology (Fudan University Institute of Dermatology-Huashan Hospital) (HS2017-1-003)

Abstract: 【Abstract】 After binding to the specific insulin-like growth factor 1 receptor (IGF1R) on the surface of target tissue cells, IGF can regulate physiological processes such as apoptosis, proliferation and senescence, which are closely related to growth and development of the body, and occurrence and development of diseases. The binding between IGF1 and IGF1Rα can cause conformational changes of the beta subunit of IGF1R, lead to activation of receptor tyrosine kinase, initiation of the downstream phosphatidylinositol 3-kinase pathway and mitogen-activated protein kinase pathway, and finally participate in the occurrence of acne, psoriasis and other skin diseases. This review summarizes research advances in the role of the IGF1R signaling pathway in the pathogenesis of related skin diseases.

Key words: Insulin-like growth factorⅠ, Phosphatidylinositol 3-kinases, MAP kinase signaling system, Skin diseases